

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.62635327 |
| 2 | vocalization behavior (GO:0071625) | 5.59902664 |
| 3 | protein localization to synapse (GO:0035418) | 5.40634728 |
| 4 | neuron cell-cell adhesion (GO:0007158) | 5.34731513 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.34071976 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.01196214 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.91227487 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.90700226 |
| 9 | glutamate secretion (GO:0014047) | 4.82831243 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.73227431 |
| 11 | synaptic vesicle maturation (GO:0016188) | 4.71951302 |
| 12 | locomotory exploration behavior (GO:0035641) | 4.53098086 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.47226226 |
| 14 | neurotransmitter secretion (GO:0007269) | 4.27393251 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.20524013 |
| 16 | exploration behavior (GO:0035640) | 4.19531962 |
| 17 | postsynaptic membrane organization (GO:0001941) | 4.16703597 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.15542217 |
| 19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.15534987 |
| 20 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.13721030 |
| 21 | layer formation in cerebral cortex (GO:0021819) | 3.97560049 |
| 22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.91888260 |
| 23 | proline transport (GO:0015824) | 3.84465561 |
| 24 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.83429045 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 3.83200541 |
| 26 | regulation of synapse structural plasticity (GO:0051823) | 3.79386624 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 3.77980192 |
| 28 | positive regulation of synapse maturation (GO:0090129) | 3.77771080 |
| 29 | neuronal action potential propagation (GO:0019227) | 3.76589381 |
| 30 | neuron recognition (GO:0008038) | 3.73523397 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 3.71149526 |
| 32 | nucleobase catabolic process (GO:0046113) | 3.70442547 |
| 33 | presynaptic membrane assembly (GO:0097105) | 3.68650060 |
| 34 | neurotransmitter transport (GO:0006836) | 3.60519660 |
| 35 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.57540573 |
| 36 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.56540003 |
| 37 | cell migration in hindbrain (GO:0021535) | 3.56198744 |
| 38 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.55247321 |
| 39 | axon ensheathment in central nervous system (GO:0032291) | 3.50273524 |
| 40 | central nervous system myelination (GO:0022010) | 3.50273524 |
| 41 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.50111281 |
| 42 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.49582961 |
| 43 | innervation (GO:0060384) | 3.47649483 |
| 44 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.47171344 |
| 45 | regulation of neurotransmitter secretion (GO:0046928) | 3.46567471 |
| 46 | long-term synaptic potentiation (GO:0060291) | 3.46317269 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 3.43221961 |
| 48 | regulation of vesicle fusion (GO:0031338) | 3.42304317 |
| 49 | cerebellar granule cell differentiation (GO:0021707) | 3.41899028 |
| 50 | synaptic vesicle endocytosis (GO:0048488) | 3.41345956 |
| 51 | synapse assembly (GO:0007416) | 3.41087757 |
| 52 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.41079387 |
| 53 | cellular potassium ion homeostasis (GO:0030007) | 3.40861429 |
| 54 | establishment of mitochondrion localization (GO:0051654) | 3.39154901 |
| 55 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.38903374 |
| 56 | presynaptic membrane organization (GO:0097090) | 3.38130415 |
| 57 | response to histamine (GO:0034776) | 3.37541929 |
| 58 | L-amino acid import (GO:0043092) | 3.35461255 |
| 59 | positive regulation of membrane potential (GO:0045838) | 3.34754510 |
| 60 | auditory behavior (GO:0031223) | 3.34313970 |
| 61 | response to auditory stimulus (GO:0010996) | 3.31560202 |
| 62 | adult walking behavior (GO:0007628) | 3.31209358 |
| 63 | regulation of postsynaptic membrane potential (GO:0060078) | 3.30944413 |
| 64 | neuronal ion channel clustering (GO:0045161) | 3.30811536 |
| 65 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.29140138 |
| 66 | neurotransmitter uptake (GO:0001504) | 3.25658765 |
| 67 | axonal fasciculation (GO:0007413) | 3.25158668 |
| 68 | sodium ion export (GO:0071436) | 3.24820423 |
| 69 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.24616498 |
| 70 | regulation of neurotransmitter levels (GO:0001505) | 3.23568035 |
| 71 | C4-dicarboxylate transport (GO:0015740) | 3.23315845 |
| 72 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.22589673 |
| 73 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.22044990 |
| 74 | gamma-aminobutyric acid transport (GO:0015812) | 3.21016280 |
| 75 | regulation of neurotransmitter transport (GO:0051588) | 3.20978329 |
| 76 | negative regulation of microtubule polymerization (GO:0031115) | 3.20251640 |
| 77 | positive regulation of neurotransmitter transport (GO:0051590) | 3.15876375 |
| 78 | transmission of nerve impulse (GO:0019226) | 3.15862966 |
| 79 | long-term memory (GO:0007616) | 3.15157165 |
| 80 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.08682879 |
| 81 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.06866287 |
| 82 | regulation of synaptic plasticity (GO:0048167) | 3.06862207 |
| 83 | positive regulation of synapse assembly (GO:0051965) | 3.06726914 |
| 84 | potassium ion import (GO:0010107) | 3.06265982 |
| 85 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.05431171 |
| 86 | membrane hyperpolarization (GO:0060081) | 3.04478052 |
| 87 | membrane depolarization during action potential (GO:0086010) | 3.02908087 |
| 88 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.00519083 |
| 89 | mating behavior (GO:0007617) | 3.00443586 |
| 90 | behavioral response to cocaine (GO:0048148) | 3.00262542 |
| 91 | regulation of neurotransmitter uptake (GO:0051580) | 2.99863785 |
| 92 | behavioral fear response (GO:0001662) | 2.99726230 |
| 93 | behavioral defense response (GO:0002209) | 2.99726230 |
| 94 | synaptic vesicle transport (GO:0048489) | 2.99474303 |
| 95 | establishment of synaptic vesicle localization (GO:0097480) | 2.99474303 |
| 96 | dendrite morphogenesis (GO:0048813) | 2.99286998 |
| 97 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.97507198 |
| 98 | synaptic transmission (GO:0007268) | 2.97505374 |
| 99 | positive regulation of dendritic spine development (GO:0060999) | 2.97279506 |
| 100 | regulation of synapse maturation (GO:0090128) | 2.96752664 |
| 101 | fear response (GO:0042596) | 2.96557890 |
| 102 | negative regulation of dendrite development (GO:2000171) | 2.96353185 |
| 103 | serotonin metabolic process (GO:0042428) | 2.95946749 |
| 104 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.95388699 |
| 105 | mechanosensory behavior (GO:0007638) | 2.95289835 |
| 106 | learning (GO:0007612) | 2.94914529 |
| 107 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.94692596 |
| 108 | vesicle transport along microtubule (GO:0047496) | 2.94007119 |
| 109 | membrane depolarization (GO:0051899) | 2.93782933 |
| 110 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.93525612 |
| 111 | neuromuscular synaptic transmission (GO:0007274) | 2.92889569 |
| 112 | startle response (GO:0001964) | 2.92565905 |
| 113 | positive regulation of synaptic transmission (GO:0050806) | 2.92552864 |
| 114 | striatum development (GO:0021756) | 2.92190933 |
| 115 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.91509778 |
| 116 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.91169023 |
| 117 | synapse organization (GO:0050808) | 2.91160211 |
| 118 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.89903692 |
| 119 | activation of protein kinase A activity (GO:0034199) | 2.89004282 |
| 120 | neurofilament cytoskeleton organization (GO:0060052) | 2.88601927 |
| 121 | prepulse inhibition (GO:0060134) | 2.88001314 |
| 122 | establishment of vesicle localization (GO:0051650) | 2.85638396 |
| 123 | cochlea development (GO:0090102) | 2.84328243 |
| 124 | acidic amino acid transport (GO:0015800) | 2.82067414 |
| 125 | adult behavior (GO:0030534) | 2.81769481 |
| 126 | regulation of dendritic spine development (GO:0060998) | 2.81158803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.76155631 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.73481251 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14423489 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.05300864 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.93509816 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.78525167 |
| 7 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.64418498 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.62357210 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.60815604 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.60815604 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.59863794 |
| 12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.57693355 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46736171 |
| 14 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.45220925 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43612026 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.40485646 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34342289 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.28890503 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.25398474 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.23397858 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.21771331 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.20526184 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.17922177 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13518833 |
| 25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.05102335 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.00374462 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.98635528 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.97084770 |
| 29 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.96431795 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.85118413 |
| 31 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.83485314 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81109561 |
| 33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77292917 |
| 34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.71427535 |
| 35 | * ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.68087842 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.66608008 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.64983011 |
| 38 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.64681763 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.64227661 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.61041741 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59755620 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.54759884 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52395385 |
| 44 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.48676847 |
| 45 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.47906645 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.46012783 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45465599 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45358815 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.44703315 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44094639 |
| 51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42667791 |
| 52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.41352338 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.40579348 |
| 54 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39310534 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37853020 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35339566 |
| 57 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34245611 |
| 58 | VDR_22108803_ChIP-Seq_LS180_Human | 1.30921217 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30274226 |
| 60 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30268499 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.29541491 |
| 62 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29534818 |
| 63 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.25573576 |
| 64 | FUS_26573619_Chip-Seq_HEK293_Human | 1.23619835 |
| 65 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.23008107 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19774052 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18894078 |
| 68 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.17623950 |
| 69 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17175508 |
| 70 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16431442 |
| 71 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16152976 |
| 72 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14094802 |
| 73 | EWS_26573619_Chip-Seq_HEK293_Human | 1.13871712 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12460634 |
| 75 | * AR_19668381_ChIP-Seq_PC3_Human | 1.09773983 |
| 76 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.09505217 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08942613 |
| 78 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08735762 |
| 79 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08573515 |
| 80 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07788988 |
| 81 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.07786679 |
| 82 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07325882 |
| 83 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07301298 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06740000 |
| 85 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.06674564 |
| 86 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06564773 |
| 87 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05315321 |
| 88 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04501682 |
| 89 | * JUN_21703547_ChIP-Seq_K562_Human | 1.04100513 |
| 90 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.03110194 |
| 91 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.03025650 |
| 92 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02873060 |
| 93 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02275640 |
| 94 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01599289 |
| 95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01599289 |
| 96 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01431868 |
| 97 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97058483 |
| 98 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.96672752 |
| 99 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96313874 |
| 100 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95204095 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93655674 |
| 102 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.92344461 |
| 103 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.92344461 |
| 104 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.92051523 |
| 105 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91734004 |
| 106 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91276832 |
| 107 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91098815 |
| 108 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90970244 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90355790 |
| 110 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90354739 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88869993 |
| 112 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88044780 |
| 113 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.87805710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.07351104 |
| 2 | MP0003880_abnormal_central_pattern | 4.55007085 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.73864376 |
| 4 | MP0004270_analgesia | 3.64160547 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.29102206 |
| 6 | MP0009745_abnormal_behavioral_response | 3.11291266 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.07963346 |
| 8 | MP0002064_seizures | 2.88273340 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.86779733 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.86288371 |
| 11 | MP0009046_muscle_twitch | 2.85863065 |
| 12 | MP0002736_abnormal_nociception_after | 2.74865595 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.68235680 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.64368748 |
| 15 | MP0002822_catalepsy | 2.55010366 |
| 16 | MP0002272_abnormal_nervous_system | 2.48527458 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.41994694 |
| 18 | MP0001486_abnormal_startle_reflex | 2.41911289 |
| 19 | MP0002733_abnormal_thermal_nociception | 2.23856128 |
| 20 | MP0005551_abnormal_eye_electrophysiolog | 2.19434251 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.16870958 |
| 22 | MP0001984_abnormal_olfaction | 2.13705730 |
| 23 | MP0001970_abnormal_pain_threshold | 2.11610923 |
| 24 | MP0002067_abnormal_sensory_capabilities | 2.08891499 |
| 25 | MP0002184_abnormal_innervation | 2.08697962 |
| 26 | MP0000778_abnormal_nervous_system | 2.03205599 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.98911412 |
| 28 | MP0004858_abnormal_nervous_system | 1.88750148 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.78152289 |
| 30 | MP0004924_abnormal_behavior | 1.77106626 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.77106626 |
| 32 | MP0001529_abnormal_vocalization | 1.75596748 |
| 33 | MP0008877_abnormal_DNA_methylation | 1.72532584 |
| 34 | MP0003329_amyloid_beta_deposits | 1.68299363 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.67693546 |
| 36 | MP0004811_abnormal_neuron_physiology | 1.63921563 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.63474759 |
| 38 | MP0008569_lethality_at_weaning | 1.57713119 |
| 39 | MP0002882_abnormal_neuron_morphology | 1.57659778 |
| 40 | MP0001905_abnormal_dopamine_level | 1.57589281 |
| 41 | MP0000955_abnormal_spinal_cord | 1.56426968 |
| 42 | MP0002638_abnormal_pupillary_reflex | 1.53308038 |
| 43 | MP0001502_abnormal_circadian_rhythm | 1.49055147 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.44795903 |
| 45 | MP0003879_abnormal_hair_cell | 1.43902122 |
| 46 | MP0003121_genomic_imprinting | 1.42981666 |
| 47 | MP0001188_hyperpigmentation | 1.39574445 |
| 48 | MP0006072_abnormal_retinal_apoptosis | 1.38816875 |
| 49 | MP0003122_maternal_imprinting | 1.38436244 |
| 50 | MP0010386_abnormal_urinary_bladder | 1.37920411 |
| 51 | MP0004142_abnormal_muscle_tone | 1.37709533 |
| 52 | MP0002066_abnormal_motor_capabilities/c | 1.34235141 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.29923625 |
| 54 | MP0003787_abnormal_imprinting | 1.29614096 |
| 55 | MP0005253_abnormal_eye_physiology | 1.23446811 |
| 56 | MP0002229_neurodegeneration | 1.20369330 |
| 57 | MP0003690_abnormal_glial_cell | 1.19922446 |
| 58 | MP0000751_myopathy | 1.18333349 |
| 59 | MP0002752_abnormal_somatic_nervous | 1.17429207 |
| 60 | MP0005394_taste/olfaction_phenotype | 1.12955165 |
| 61 | MP0005499_abnormal_olfactory_system | 1.12955165 |
| 62 | MP0002090_abnormal_vision | 1.12768726 |
| 63 | MP0003633_abnormal_nervous_system | 1.12243873 |
| 64 | MP0002152_abnormal_brain_morphology | 1.10184118 |
| 65 | MP0003136_yellow_coat_color | 1.09219832 |
| 66 | MP0004885_abnormal_endolymph | 1.04262798 |
| 67 | MP0000631_abnormal_neuroendocrine_gland | 1.01907450 |
| 68 | MP0000920_abnormal_myelination | 1.00622813 |
| 69 | MP0002876_abnormal_thyroid_physiology | 1.00509942 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 0.99956254 |
| 71 | MP0003631_nervous_system_phenotype | 0.99229745 |
| 72 | MP0001963_abnormal_hearing_physiology | 0.96928460 |
| 73 | MP0006292_abnormal_olfactory_placode | 0.94740389 |
| 74 | MP0003634_abnormal_glial_cell | 0.94368693 |
| 75 | MP0004742_abnormal_vestibular_system | 0.93799313 |
| 76 | MP0008872_abnormal_physiological_respon | 0.92700318 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.92139754 |
| 78 | MP0004133_heterotaxia | 0.90846512 |
| 79 | MP0002069_abnormal_eating/drinking_beha | 0.88988685 |
| 80 | MP0002751_abnormal_autonomic_nervous | 0.88520027 |
| 81 | MP0003011_delayed_dark_adaptation | 0.85194306 |
| 82 | MP0005195_abnormal_posterior_eye | 0.82066136 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.81645359 |
| 84 | MP0005535_abnormal_body_temperature | 0.75224144 |
| 85 | MP0008789_abnormal_olfactory_epithelium | 0.75023994 |
| 86 | MP0004085_abnormal_heartbeat | 0.74990465 |
| 87 | MP0000566_synostosis | 0.74891138 |
| 88 | MP0004233_abnormal_muscle_weight | 0.74234730 |
| 89 | MP0005187_abnormal_penis_morphology | 0.73510545 |
| 90 | MP0004215_abnormal_myocardial_fiber | 0.73238957 |
| 91 | MP0000026_abnormal_inner_ear | 0.72437039 |
| 92 | MP0003632_abnormal_nervous_system | 0.70297815 |
| 93 | MP0004147_increased_porphyrin_level | 0.70109034 |
| 94 | MP0004145_abnormal_muscle_electrophysio | 0.69924681 |
| 95 | MP0002653_abnormal_ependyma_morphology | 0.69777034 |
| 96 | MP0001664_abnormal_digestion | 0.67432218 |
| 97 | MP0008874_decreased_physiological_sensi | 0.67208491 |
| 98 | MP0000604_amyloidosis | 0.67204446 |
| 99 | MP0005409_darkened_coat_color | 0.66312246 |
| 100 | MP0003938_abnormal_ear_development | 0.64845988 |
| 101 | MP0002102_abnormal_ear_morphology | 0.64634379 |
| 102 | MP0003890_abnormal_embryonic-extraembry | 0.64297357 |
| 103 | MP0000013_abnormal_adipose_tissue | 0.63345800 |
| 104 | MP0003861_abnormal_nervous_system | 0.62609139 |
| 105 | MP0010769_abnormal_survival | 0.60821469 |
| 106 | MP0003123_paternal_imprinting | 0.60602960 |
| 107 | MP0004043_abnormal_pH_regulation | 0.60001163 |
| 108 | MP0001299_abnormal_eye_distance/ | 0.58932482 |
| 109 | MP0001177_atelectasis | 0.56484066 |
| 110 | MP0001943_abnormal_respiration | 0.54865771 |
| 111 | MP0001485_abnormal_pinna_reflex | 0.54511541 |
| 112 | MP0003137_abnormal_impulse_conducting | 0.54268238 |
| 113 | MP0002082_postnatal_lethality | 0.49644330 |
| 114 | MP0010770_preweaning_lethality | 0.49644330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.68699096 |
| 2 | * Myokymia (HP:0002411) | 5.31127229 |
| 3 | Focal seizures (HP:0007359) | 5.07826291 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.04512863 |
| 5 | Atonic seizures (HP:0010819) | 4.67287478 |
| 6 | Visual hallucinations (HP:0002367) | 4.61410251 |
| 7 | Febrile seizures (HP:0002373) | 4.58567348 |
| 8 | Hyperventilation (HP:0002883) | 4.48840601 |
| 9 | Absence seizures (HP:0002121) | 4.20773641 |
| 10 | Congenital stationary night blindness (HP:0007642) | 3.84880273 |
| 11 | Dialeptic seizures (HP:0011146) | 3.74208160 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.61869662 |
| 13 | * Progressive cerebellar ataxia (HP:0002073) | 3.45806248 |
| 14 | Limb dystonia (HP:0002451) | 3.37334061 |
| 15 | Gait imbalance (HP:0002141) | 3.21210898 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.16413723 |
| 17 | Diplopia (HP:0000651) | 3.13352441 |
| 18 | Abnormality of binocular vision (HP:0011514) | 3.13352441 |
| 19 | Broad-based gait (HP:0002136) | 3.12743072 |
| 20 | Amblyopia (HP:0000646) | 3.05009936 |
| 21 | Abnormality of the labia minora (HP:0012880) | 3.03748312 |
| 22 | Central scotoma (HP:0000603) | 3.03189651 |
| 23 | Mutism (HP:0002300) | 3.02080235 |
| 24 | Polyphagia (HP:0002591) | 3.01236374 |
| 25 | Ankle clonus (HP:0011448) | 2.98121902 |
| 26 | Pheochromocytoma (HP:0002666) | 2.89341678 |
| 27 | Abnormal eating behavior (HP:0100738) | 2.86310242 |
| 28 | Truncal ataxia (HP:0002078) | 2.80806995 |
| 29 | Drooling (HP:0002307) | 2.73330328 |
| 30 | Excessive salivation (HP:0003781) | 2.73330328 |
| 31 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.69933586 |
| 32 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.69933586 |
| 33 | Epileptiform EEG discharges (HP:0011182) | 2.69376961 |
| 34 | Congenital primary aphakia (HP:0007707) | 2.67036502 |
| 35 | Neuroendocrine neoplasm (HP:0100634) | 2.60121383 |
| 36 | Poor eye contact (HP:0000817) | 2.60020492 |
| 37 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.59838686 |
| 38 | EEG with generalized epileptiform discharges (HP:0011198) | 2.59472083 |
| 39 | Insidious onset (HP:0003587) | 2.59208508 |
| 40 | Termporal pattern (HP:0011008) | 2.59208508 |
| 41 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.58818099 |
| 42 | Medial flaring of the eyebrow (HP:0010747) | 2.58800317 |
| 43 | Abnormality of macular pigmentation (HP:0008002) | 2.57026286 |
| 44 | Hemiplegia (HP:0002301) | 2.51731779 |
| 45 | Gaze-evoked nystagmus (HP:0000640) | 2.51691242 |
| 46 | Hemiparesis (HP:0001269) | 2.51406754 |
| 47 | Nephrogenic diabetes insipidus (HP:0009806) | 2.44051953 |
| 48 | * Anxiety (HP:0000739) | 2.41927576 |
| 49 | Progressive inability to walk (HP:0002505) | 2.41345601 |
| 50 | Split foot (HP:0001839) | 2.39933182 |
| 51 | Impaired social interactions (HP:0000735) | 2.39549712 |
| 52 | Abnormal social behavior (HP:0012433) | 2.39549712 |
| 53 | * Depression (HP:0000716) | 2.39169666 |
| 54 | Cerebral inclusion bodies (HP:0100314) | 2.38671952 |
| 55 | Hypsarrhythmia (HP:0002521) | 2.36797228 |
| 56 | Abnormality of the corticospinal tract (HP:0002492) | 2.34671713 |
| 57 | Scotoma (HP:0000575) | 2.32240690 |
| 58 | Urinary urgency (HP:0000012) | 2.31081730 |
| 59 | Specific learning disability (HP:0001328) | 2.30714558 |
| 60 | Failure to thrive in infancy (HP:0001531) | 2.29494449 |
| 61 | Torticollis (HP:0000473) | 2.29366318 |
| 62 | Intention tremor (HP:0002080) | 2.27751791 |
| 63 | Neurofibrillary tangles (HP:0002185) | 2.26449744 |
| 64 | Inability to walk (HP:0002540) | 2.26339618 |
| 65 | Genetic anticipation (HP:0003743) | 2.25490149 |
| 66 | Sleep apnea (HP:0010535) | 2.23495324 |
| 67 | Fetal akinesia sequence (HP:0001989) | 2.23283504 |
| 68 | Genital tract atresia (HP:0001827) | 2.22723404 |
| 69 | Spastic tetraplegia (HP:0002510) | 2.22463231 |
| 70 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.21372677 |
| 71 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.21113305 |
| 72 | Spastic gait (HP:0002064) | 2.20757249 |
| 73 | Megalencephaly (HP:0001355) | 2.18701328 |
| 74 | Vaginal atresia (HP:0000148) | 2.17433542 |
| 75 | Absent speech (HP:0001344) | 2.14539874 |
| 76 | Hypoventilation (HP:0002791) | 2.14477831 |
| 77 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.12852628 |
| 78 | Bradykinesia (HP:0002067) | 2.12589163 |
| 79 | Postural instability (HP:0002172) | 2.11588272 |
| 80 | Focal dystonia (HP:0004373) | 2.10054319 |
| 81 | Abnormal hair whorl (HP:0010721) | 2.05157476 |
| 82 | Poor suck (HP:0002033) | 2.04509528 |
| 83 | Protruding tongue (HP:0010808) | 2.03959880 |
| 84 | Hypoplasia of the brainstem (HP:0002365) | 2.03862480 |
| 85 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.03862480 |
| 86 | Nephronophthisis (HP:0000090) | 2.03089368 |
| 87 | * Dysmetria (HP:0001310) | 2.02839108 |
| 88 | * Dysdiadochokinesis (HP:0002075) | 2.02261421 |
| 89 | Pancreatic fibrosis (HP:0100732) | 2.00048200 |
| 90 | Hypothermia (HP:0002045) | 1.99554450 |
| 91 | True hermaphroditism (HP:0010459) | 1.99286281 |
| 92 | Lower limb muscle weakness (HP:0007340) | 1.97148163 |
| 93 | Craniofacial dystonia (HP:0012179) | 1.96392380 |
| 94 | Agitation (HP:0000713) | 1.96159322 |
| 95 | Akinesia (HP:0002304) | 1.94795877 |
| 96 | Oligodactyly (hands) (HP:0001180) | 1.93672944 |
| 97 | Generalized myoclonic seizures (HP:0002123) | 1.92817619 |
| 98 | Esotropia (HP:0000565) | 1.92155521 |
| 99 | Scanning speech (HP:0002168) | 1.91976310 |
| 100 | * Action tremor (HP:0002345) | 1.90181520 |
| 101 | Lissencephaly (HP:0001339) | 1.89588054 |
| 102 | Decreased central vision (HP:0007663) | 1.88739360 |
| 103 | Poor coordination (HP:0002370) | 1.88241307 |
| 104 | Molar tooth sign on MRI (HP:0002419) | 1.87625653 |
| 105 | Abnormality of midbrain morphology (HP:0002418) | 1.87625653 |
| 106 | Hyperthyroidism (HP:0000836) | 1.87175867 |
| 107 | Stereotypic behavior (HP:0000733) | 1.86666365 |
| 108 | Retinal dysplasia (HP:0007973) | 1.86645869 |
| 109 | Optic nerve hypoplasia (HP:0000609) | 1.86624797 |
| 110 | Abnormality of salivation (HP:0100755) | 1.85820497 |
| 111 | Type II lissencephaly (HP:0007260) | 1.85330779 |
| 112 | Impaired smooth pursuit (HP:0007772) | 1.85185951 |
| 113 | Cerebral hypomyelination (HP:0006808) | 1.84991763 |
| 114 | Status epilepticus (HP:0002133) | 1.84641797 |
| 115 | Incomplete penetrance (HP:0003829) | 1.82807541 |
| 116 | Pancreatic cysts (HP:0001737) | 1.81606118 |
| 117 | Impaired vibratory sensation (HP:0002495) | 1.81300499 |
| 118 | Abnormality of the lower motor neuron (HP:0002366) | 1.81048886 |
| 119 | Blue irides (HP:0000635) | 1.80164939 |
| 120 | Amyotrophic lateral sclerosis (HP:0007354) | 1.79355055 |
| 121 | Impaired pain sensation (HP:0007328) | 1.79236695 |
| 122 | Pachygyria (HP:0001302) | 1.77002736 |
| 123 | Spastic tetraparesis (HP:0001285) | 1.76350249 |
| 124 | Hypoplasia of the corpus callosum (HP:0002079) | 1.73287082 |
| 125 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.68983680 |
| 126 | Muscular hypotonia of the trunk (HP:0008936) | 1.68488175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.00780188 |
| 2 | CASK | 3.82041148 |
| 3 | NTRK3 | 3.79536217 |
| 4 | EPHA4 | 3.43590226 |
| 5 | MAP3K4 | 3.30810193 |
| 6 | MAP3K9 | 3.27326016 |
| 7 | MAP2K7 | 3.12024613 |
| 8 | MINK1 | 2.81867267 |
| 9 | MAP3K12 | 2.70436340 |
| 10 | NTRK2 | 2.21446840 |
| 11 | DAPK2 | 2.00844018 |
| 12 | MAP2K4 | 1.94250858 |
| 13 | FRK | 1.92370241 |
| 14 | PAK6 | 1.89328807 |
| 15 | PLK2 | 1.81282900 |
| 16 | MAPK13 | 1.76944298 |
| 17 | GRK5 | 1.75957046 |
| 18 | PHKG1 | 1.75429499 |
| 19 | PHKG2 | 1.75429499 |
| 20 | NTRK1 | 1.64384673 |
| 21 | RIPK4 | 1.61701769 |
| 22 | KSR1 | 1.48166358 |
| 23 | KSR2 | 1.47469222 |
| 24 | PNCK | 1.45974804 |
| 25 | TNIK | 1.43488264 |
| 26 | CDK5 | 1.41422305 |
| 27 | DAPK1 | 1.39208053 |
| 28 | PRPF4B | 1.38083326 |
| 29 | PRKCG | 1.26155671 |
| 30 | CDK19 | 1.20892409 |
| 31 | SIK2 | 1.20110745 |
| 32 | ARAF | 1.17901442 |
| 33 | LMTK2 | 1.17586718 |
| 34 | TRIM28 | 1.17506332 |
| 35 | CAMKK1 | 1.16002037 |
| 36 | MAP4K2 | 1.13409239 |
| 37 | NME1 | 1.10775474 |
| 38 | SIK3 | 1.09239418 |
| 39 | TAOK1 | 1.04918362 |
| 40 | CAMK2A | 1.04798776 |
| 41 | UHMK1 | 1.01015865 |
| 42 | PRKD3 | 0.99099983 |
| 43 | CCNB1 | 0.98365629 |
| 44 | LATS2 | 0.96643185 |
| 45 | SGK223 | 0.95986466 |
| 46 | SGK494 | 0.95986466 |
| 47 | PKN1 | 0.95811558 |
| 48 | FGFR2 | 0.95434847 |
| 49 | CSNK1A1L | 0.94580612 |
| 50 | CDK18 | 0.93051402 |
| 51 | FES | 0.91842932 |
| 52 | CSNK1G1 | 0.91782162 |
| 53 | CDK14 | 0.91557164 |
| 54 | DYRK1A | 0.89955826 |
| 55 | BMPR1B | 0.87261497 |
| 56 | CDK15 | 0.86544238 |
| 57 | CSNK1G2 | 0.81574239 |
| 58 | STK38 | 0.79914937 |
| 59 | CAMKK2 | 0.76605003 |
| 60 | TAOK2 | 0.76470899 |
| 61 | DYRK2 | 0.76384533 |
| 62 | GRK7 | 0.75233929 |
| 63 | PAK3 | 0.74990421 |
| 64 | SGK2 | 0.74486275 |
| 65 | CDK11A | 0.73932703 |
| 66 | BMPR2 | 0.71195379 |
| 67 | CAMK2B | 0.70754173 |
| 68 | BCR | 0.70700548 |
| 69 | RET | 0.69422197 |
| 70 | OXSR1 | 0.68695725 |
| 71 | PRKCE | 0.67628432 |
| 72 | ADRBK1 | 0.66989252 |
| 73 | INSRR | 0.66843295 |
| 74 | MAP3K2 | 0.66605800 |
| 75 | MKNK2 | 0.64649803 |
| 76 | TYRO3 | 0.62318106 |
| 77 | PTK2B | 0.61067146 |
| 78 | MAPK15 | 0.60886835 |
| 79 | PRKCZ | 0.60535632 |
| 80 | AKT3 | 0.57841162 |
| 81 | WNK3 | 0.57837423 |
| 82 | PINK1 | 0.56682108 |
| 83 | STK11 | 0.55637671 |
| 84 | FGR | 0.55510832 |
| 85 | LIMK1 | 0.54013389 |
| 86 | CAMK4 | 0.53748929 |
| 87 | MAP3K13 | 0.52221075 |
| 88 | SGK1 | 0.52214160 |
| 89 | CSNK1D | 0.51473332 |
| 90 | FER | 0.51185307 |
| 91 | TSSK6 | 0.51100008 |
| 92 | NEK1 | 0.50848330 |
| 93 | CAMK1 | 0.50041659 |
| 94 | MAP2K1 | 0.49428059 |
| 95 | CAMK2D | 0.48302372 |
| 96 | PRKG1 | 0.47860107 |
| 97 | MARK2 | 0.47622265 |
| 98 | NEK6 | 0.47042103 |
| 99 | PDK4 | 0.46904882 |
| 100 | PDK3 | 0.46904882 |
| 101 | GRK1 | 0.45611576 |
| 102 | CSNK1A1 | 0.43933697 |
| 103 | ERBB3 | 0.43796134 |
| 104 | MAPK10 | 0.43121192 |
| 105 | MAP3K1 | 0.42053524 |
| 106 | CSNK1G3 | 0.42008565 |
| 107 | MAPK12 | 0.41941125 |
| 108 | TNK2 | 0.41913254 |
| 109 | WNK4 | 0.41884085 |
| 110 | RAF1 | 0.40053432 |
| 111 | SGK3 | 0.39590757 |
| 112 | CSNK1E | 0.39479158 |
| 113 | CAMK2G | 0.39268575 |
| 114 | MAP3K6 | 0.38196862 |
| 115 | PRKCH | 0.37893713 |
| 116 | ROCK2 | 0.37773808 |
| 117 | PRKCA | 0.37562138 |
| 118 | PRKACB | 0.36548563 |
| 119 | RPS6KA3 | 0.36523856 |
| 120 | PRKACA | 0.35516191 |
| 121 | STK39 | 0.35354017 |
| 122 | ERBB2 | 0.35298160 |
| 123 | RPS6KA2 | 0.35288556 |
| 124 | PRKCB | 0.35066053 |
| 125 | ADRBK2 | 0.34345974 |
| 126 | PLK3 | 0.34291876 |
| 127 | BRAF | 0.33950605 |
| 128 | FYN | 0.33341756 |
| 129 | MAP3K11 | 0.33100793 |
| 130 | ZAK | 0.32926329 |
| 131 | ALK | 0.32422228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.92588233 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.82159454 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 2.82214681 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75752553 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.73539863 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.65317307 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.52242714 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.45127635 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.38506072 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.28485557 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.23782608 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.18187480 |
| 13 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.17660129 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.15240124 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.99433495 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.93897998 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.92647156 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.89831883 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.88551807 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.69461485 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.65177555 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.60055183 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.57742211 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55731631 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.51810190 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.48099418 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.45620635 |
| 28 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.44853377 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.37754703 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.32717933 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.31806798 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30959730 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.30383671 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.29301981 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.25352727 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25126021 |
| 37 | Axon guidance_Homo sapiens_hsa04360 | 1.23600303 |
| 38 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.19227161 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13679438 |
| 40 | Alzheimers disease_Homo sapiens_hsa05010 | 1.03555394 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03431786 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.03381031 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03044188 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02582308 |
| 45 | Parkinsons disease_Homo sapiens_hsa05012 | 0.98118383 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95793843 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93204430 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93191473 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 0.91273081 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.91177893 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90401883 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87440484 |
| 53 | Glioma_Homo sapiens_hsa05214 | 0.87355770 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85705490 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77833652 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77214757 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.75159581 |
| 58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74897798 |
| 59 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73949531 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72403765 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65391623 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65333243 |
| 63 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64744769 |
| 64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.64265166 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61550093 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60331344 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58689374 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58541762 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.58389724 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57952347 |
| 71 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56988424 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56706965 |
| 73 | Protein export_Homo sapiens_hsa03060 | 0.55562187 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55557223 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55102299 |
| 76 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55022252 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54880491 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54423143 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54332435 |
| 80 | Alcoholism_Homo sapiens_hsa05034 | 0.54229533 |
| 81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.53104702 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51939386 |
| 83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51755645 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50887769 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50098046 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49816424 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49061012 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48103505 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46739657 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45886205 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45543010 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44867740 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43799167 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42838152 |
| 95 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42739030 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.42641306 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41790642 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41552042 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40356444 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39288511 |
| 101 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38478056 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38300060 |
| 103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38197722 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38187010 |
| 105 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37631696 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37356240 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37298721 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36144633 |
| 109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35932913 |
| 110 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.35250324 |
| 111 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34303019 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33951543 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32751087 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.32412624 |
| 115 | * Hippo signaling pathway_Homo sapiens_hsa04390 | 0.31399713 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31287297 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29876087 |
| 118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.29659048 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.28259245 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.27915646 |
| 121 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.27651429 |
| 122 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27583301 |
| 123 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.27246083 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24933882 |

